Delenex Therapeutics AG

Delenex Therapeutics AG is a well-recognised, innovative, clinical stage Swiss biotech company located in the Zürich area. With our proprietary PENTRA®Bodies we aim at extending the benefits of proven antibody therapeutics to a much larger number of patients. Currently, we are focusing on the development of novel, potent and safe antibody therapeutics that are topically applied.
 

Details


Adresse:
Delenex Therapeutics AG

Wagistr. 27
8952 Schlieren (Zürich)
Schweiz
Arbeitsgebiet:
Klinische Forschung
Forschung & Entwicklung
Expansion:
international
Webseite:
Mitarbeiteranzahl:
11-50
Gründungsjahr:
2009